604 related articles for article (PubMed ID: 33849457)
1. The microbial diversity following antibiotic treatment of Clostridioides difficile infection.
Binyamin D; Nitzan O; Azrad M; Hamo Z; Koren O; Peretz A
BMC Gastroenterol; 2021 Apr; 21(1):166. PubMed ID: 33849457
[TBL] [Abstract][Full Text] [Related]
2. Diluted Fecal Community Transplant Restores Clostridioides difficile Colonization Resistance to Antibiotic-Perturbed Murine Communities.
Lesniak NA; Tomkovich S; Henry A; Taylor A; Colovas J; Bishop L; McBride K; Schloss PD
mBio; 2022 Aug; 13(4):e0136422. PubMed ID: 35913161
[TBL] [Abstract][Full Text] [Related]
3. Response of the gut microbiota during the Clostridioides difficile infection in tree shrews mimics those in humans.
Gu W; Li W; Wang W; Kuang D; Zhang W; Lu C; Li N; Tong P; Han Y; Sun X; Lu J; Wu Y; Dai J
BMC Microbiol; 2020 Aug; 20(1):260. PubMed ID: 32819295
[TBL] [Abstract][Full Text] [Related]
4. Correlation of Clinical Severity With Stool Microbiome Changes in Clostridioides difficile Infection.
Castañeda-Mogollón D; Doolan CP; Toppings NB; Amarasekara R; Tran TA; Pillai DR
Arch Pathol Lab Med; 2023 Jul; 147(7):774-785. PubMed ID: 36308712
[TBL] [Abstract][Full Text] [Related]
5. Disordered Intestinal Microbial Communities During
Chen Y; Lv T; Yan D; Zheng L; Zheng B; Wang J; Gu S; Li L
Front Cell Infect Microbiol; 2022; 12():825189. PubMed ID: 35433508
[TBL] [Abstract][Full Text] [Related]
6. Clearance of Clostridioides difficile Colonization Is Associated with Antibiotic-Specific Bacterial Changes.
Lesniak NA; Schubert AM; Sinani H; Schloss PD
mSphere; 2021 May; 6(3):. PubMed ID: 33952668
[TBL] [Abstract][Full Text] [Related]
7. The Initial Gut Microbiota and Response to Antibiotic Perturbation Influence Clostridioides difficile Clearance in Mice.
Tomkovich S; Stough JMA; Bishop L; Schloss PD
mSphere; 2020 Oct; 5(5):. PubMed ID: 33087520
[TBL] [Abstract][Full Text] [Related]
8. Intestinal Dysbiosis and Risk of Posttransplant Clostridioides difficile Infection in a Longitudinal Cohort of Liver Transplant Recipients.
Gomez-Simmonds A; Annavajhala MK; Nunez MP; Macesic N; Park H; Uhlemann AC
mSphere; 2022 Oct; 7(5):e0036122. PubMed ID: 36135360
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection.
Khanna S; Assi M; Lee C; Yoho D; Louie T; Knapple W; Aguilar H; Garcia-Diaz J; Wang GP; Berry SM; Marion J; Su X; Braun T; Bancke L; Feuerstadt P
Drugs; 2022 Oct; 82(15):1527-1538. PubMed ID: 36287379
[TBL] [Abstract][Full Text] [Related]
10. Randomized Controlled Trial of Oral Vancomycin Treatment in Clostridioides difficile-Colonized Patients.
Fishbein SRS; Hink T; Reske KA; Cass C; Struttmann E; Iqbal ZH; Seiler S; Kwon JH; Burnham CA; Dantas G; Dubberke ER
mSphere; 2021 Jan; 6(1):. PubMed ID: 33441409
[No Abstract] [Full Text] [Related]
11. Butyrate Differentiates Permissiveness to Clostridioides difficile Infection and Influences Growth of Diverse C. difficile Isolates.
Pensinger DA; Fisher AT; Dobrila HA; Van Treuren W; Gardner JO; Higginbottom SK; Carter MM; Schumann B; Bertozzi CR; Anikst V; Martin C; Robilotti EV; Chow JM; Buck RH; Tompkins LS; Sonnenburg JL; Hryckowian AJ
Infect Immun; 2023 Feb; 91(2):e0057022. PubMed ID: 36692308
[TBL] [Abstract][Full Text] [Related]
12. Gut metabolites predict Clostridioides difficile recurrence.
Dawkins JJ; Allegretti JR; Gibson TE; McClure E; Delaney M; Bry L; Gerber GK
Microbiome; 2022 Jun; 10(1):87. PubMed ID: 35681218
[TBL] [Abstract][Full Text] [Related]
13. High Dose Intramuscular Vitamin D3 Supplementation Impacts the Gut Microbiota of Patients With
Lee SH; Park HK; Kang CD; Choi DH; Park SC; Park JM; Nam SJ; Chae GB; Lee KY; Cho H; Lee SJ
Front Cell Infect Microbiol; 2022; 12():904987. PubMed ID: 35774395
[TBL] [Abstract][Full Text] [Related]
14. 2'-Fucosyllactose inhibits proliferation of
Wiese M; Schuren FHJ; Smits WK; Kuijper EJ; Ouwens A; Heerikhuisen M; Vigsnaes L; van den Broek TJ; de Boer P; Montijn RC; van der Vossen JMBM
Front Cell Infect Microbiol; 2022; 12():991150. PubMed ID: 36389156
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the gut microbiome of patients with
Vázquez-Cuesta S; Villar L; García NL; Fernández AI; Olmedo M; Alcalá L; Marín M; Muñoz P; Bouza E; Reigadas E
Front Cell Infect Microbiol; 2023; 13():1130701. PubMed ID: 37124040
[TBL] [Abstract][Full Text] [Related]
16. Factors Related to Outcomes of Fecal Microbiota Transplantation in Patients with
Yoon H; Shim HI; Seol M; Shin CM; Park YS; Kim N; Lee DH
Gut Liver; 2021 Jan; 15(1):61-69. PubMed ID: 32839363
[TBL] [Abstract][Full Text] [Related]
17. Functional profile of host microbiome indicates
Nzabarushimana E; Tang H
Gut Microbes; 2022; 14(1):2135963. PubMed ID: 36289064
[TBL] [Abstract][Full Text] [Related]
18. Risk factors and intestinal microbiota: Clostridioides difficile infection in patients receiving enteral nutrition at Intensive Care Units.
Wang D; Dong D; Wang C; Cui Y; Jiang C; Ni Q; Su T; Wang G; Mao E; Peng Y
Crit Care; 2020 Jul; 24(1):426. PubMed ID: 32660525
[TBL] [Abstract][Full Text] [Related]
19. Intestinal Inflammation Reversibly Alters the Microbiota to Drive Susceptibility to Clostridioides difficile Colonization in a Mouse Model of Colitis.
Barron MR; Sovacool KL; Abernathy-Close L; Vendrov KC; Standke AK; Bergin IL; Schloss PD; Young VB
mBio; 2022 Aug; 13(4):e0190422. PubMed ID: 35900107
[TBL] [Abstract][Full Text] [Related]
20. Effects of β-lactam antibiotics and fluoroquinolones on human gut microbiota in relation to Clostridium difficile associated diarrhea.
Knecht H; Neulinger SC; Heinsen FA; Knecht C; Schilhabel A; Schmitz RA; Zimmermann A; dos Santos VM; Ferrer M; Rosenstiel PC; Schreiber S; Friedrichs AK; Ott SJ
PLoS One; 2014; 9(2):e89417. PubMed ID: 24586762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]